✦ LIBER ✦

Open-label, randomized, multiple-center, parallel study comparing glycemic responses and safety profiles of Glucerna versus Fresubin in subjects of type 2 diabetes mellitus

✍ Scribed by Wei-Qing Wang; Yi-Fei Zhang; Da-Jin Zhou; Zhi-Min Liu; Xu Hong; Ming-Cai Qiu; Yong-Quan Shi; Pei-Jin Xia; Jin Lu; Mao-Jing Xu; Liang An; Wei Feng; Peng Zhang; J. Schwamman; Guang Ning

Book ID: 107571164
Publisher: Springer
Year: 2008
Tongue: English
Weight: 211 KB
Volume: 33
Category: Article
ISSN: 0969-711X
DOI: 10.1007/s12020-008-9059-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter, randomized, open-label, c

A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus

✍ Mary Korytkowski; David Bell; Carol Jacobsen; Rudee Suwannasari; FlexPen® Study 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Efficacy and Safety Profile of Exenatide

Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From a 26-Week, Randomized, Open-Label, Parallel-Group, Multicenter, Noninferiority Study

✍ Inagaki, Nobuya; Atsumi, Yoshihito; Oura, Tomonori; Saito, Hitoshi; Imaoka, Take 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 962 KB